Videos
Short video to provide an overview of treatment options
Non-Muscle Invasive Bladder Cancer (NMIBC)
Videos
Short video clips from medical professionals explaining what to expect
Information
Further information to help you understand NMIBC treatment options and pathway
A detailed easy-to-understand guide to the various treatments, what they entail, why they may have been recommended and what their outcomes may be.
This 1-page flowchart will guide you through all NMIBC treatment options, and the order they are likely to happen. It includes all new immunotherapy and targeted therapy treatment availability as they move from clinical trial through to PBS reimbursement.
Muscle Invasive Bladder Cancer (MIBC)
Videos
Short video clips from medical professionals explaining what to expect
Information
Further information to help you understand MIBC treatment options and pathway
A detailed easy-to-understand guide to the various treatments, what they entail, why they may have been recommended and what their outcomes may be.
This 1-page flowchart will guide you through all MIBC treatment options, and the order they are likely to happen. It includes all new immunotherapy and targeted therapy treatment availability as they move from clinical trial through to PBS reimbursement.
This 1-page summary introduces and explains the differences between immunotherapy, targeted therapies, and how genomic profiling can inform your treatment options.
Advanced (Metastatic) Bladder Cancer
Videos
Short video clips from medical professionals explaining what to expect
Information
Further information to understand Advanced Bladder Cancer treatment options and pathway
A detailed easy-to-understand guide to the various treatments, what they entail, why they may have been recommended and what their outcomes may be.
This 1-page flowchart will guide you through all Advanced Bladder Cancer treatment options, and the order they are likely to happen. It includes all new immunotherapy and targeted therapy treatment availability as they move from clinical trial through to PBS reimbursement.
This 1-page summary introduces and explains the differences between immunotherapy, targeted therapies, and how genomic profiling can inform your treatment options.